ELTP 10-Q: SEC filing
Elite Pharmaceuticals
Filed with the SEC on · accession 0001493152-26-051384
ELTP filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. Elite Pharmaceuticals filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing financial statements including balance sheets, income statements, and segment revenue breakdowns.
Summary of the filing
Elite Pharmaceuticals filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing financial statements including balance sheets, income statements, and segment revenue breakdowns. The filing contains routine financial reporting data with no single material corporate event.
Key details
✦ Ask GOAX AI about this filing — what it means for ELTP, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ELTP?
Click hereFrequently asked questions
What did ELTP file with the SEC on Nov 12, 2026?
ELTP filed a 10-Q (SEC filing). Elite Pharmaceuticals filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing financial statements including balance sheets, income statements, and segment revenue breakdowns. The filing contains routine financial reporting data with no single material corporate event.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
Other ELTP SEC filings
Get alerts when ELTP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days